A comparison between patients with strong Nectin-4 expressing tumors and those with Nectin-4 negative tumors for tumor progression or cancer-specific mortality (0 vs. 3+) is shown in Supplementary Figure S1A,B. Here, NECTIN4 is linked to cancer.